Competitive / Unconcentrated | Moderately Concentrated | Highly Concentrated | p-value | |
---|---|---|---|---|
(n = 10,873) | (n = 6526) | (n = 15,007) | ||
Age (years) | 68.2 | 68.7 | 69.5 | < 0.01 |
Median household income | < 0.01 | |||
First quartile | 2657 (24.4%) | 1529 (23.4%) | 4094 (27.3%) | |
Second quartile | 2500 (23.0%) | 1318 (20.2%) | 4226 (28.2%) | |
Third quartile | 2705 (24.9%) | 1593 (24.4%) | 3793 (25.3%) | |
Fourth quartile | 2729 (25.1%) | 1924 (29.5%) | 2504 (16.7%) | |
Unknown | 282 (2.6%) | 162 (2.5%) | 390 (2.6%) | |
Payer status | < 0.01 | |||
Medicare | 6286 (57.8%) | 3890 (59.6%) | 9534 (63.5%) | |
Medicaid | 763 (7.0%) | 382 (5.9%) | 726 (4.8%) | |
Private insurance | 2838 (26.1%) | 1768 (27.1%) | 3542 (23.6%) | |
Self-pay / no charge / other | 986 (9.1%) | 486 (7.4%) | 1205 (8.0%) | |
Comorbid conditions | ||||
Congestive heart failure | 6000 (55.2%) | 3477 (53.3%) | 8091 (53.9%) | 0.03 |
Valvular disease | 2142 (19.7%) | 1143 (17.5%) | 2879 (19.2%) | < 0.01 |
Pulmonary circulation disorders | 564 (5.2%) | 280 (4.3%) | 647 (4.3%) | < 0.01 |
Peripheral vascular disease | 1132 (10.4%) | 628 (9.6%) | 1439 (9.6%) | 0.06 |
Paralysis | 108 (1.0%) | 52 (0.8%) | 131 (0.9%) | 0.37 |
Neurologic disease | 599 (5.5%) | 343 (5.3%) | 826 (5.5%) | 0.73 |
Chronic obstructive pulmonary disease | 2162 (19.9%) | 1464 (22.4%) | 3641 (24.3%) | < 0.01 |
Diabetes mellitus, uncomplicated | 2284 (21.0%) | 1408 (21.6%) | 3115 (20.8%) | 0.4 |
Diabetes mellitus, with chronic complications | 559 (5.1%) | 331 (5.1%) | 692 (4.6%) | 0.11 |
Hypothyroidism | 532 (4.9%) | 342 (5.2%) | 814 (5.4%) | 0.16 |
Chronic kidney disease | 1821 (16.7%) | 1179 (18.1%) | 2543 (16.9%) | 0.06 |
Liver disease | 142 (1.3%) | 85 (1.3%) | 189 (1.3%) | 0.94 |
Lymphoma | 62 (0.6%) | 33 (0.5%) | 92 (0.6%) | 0.63 |
Solid tumor without metastasis | 304 (2.8%) | 142 (2.2%) | 371 (2.5%) | 0.03 |
Metastatic cancer | 128 (1.2%) | 62 (1.0%) | 165 (1.1%) | 0.38 |
Collagen vascular disease | 145 (1.3%) | 98 (1.5%) | 228 (1.5%) | 0.44 |
Coagulopathy | 1337 (12.3%) | 671 (10.3%) | 1336 (8.9%) | < 0.01 |
Obesity | 508 (4.7%) | 365 (5.6%) | 828 (5.5%) | < 0.01 |
Weight loss | 641 (5.9%) | 423 (6.5%) | 804 (5.4%) | < 0.01 |
Fluid and electrolyte disorders | 3973 (36.5%) | 2435 (37.3%) | 5278 (35.2%) | < 0.01 |
Chronic blood loss anemia | 188 (1.7%) | 118 (1.8%) | 279 (1.9%) | 0.74 |
Deficiency anemia | 1325 (12.2%) | 922 (14.1%) | 1753 (11.7%) | < 0.01 |
Alcohol abuse | 347 (3.2%) | 168 (2.6%) | 452 (3.0%) | 0.07 |
Drug abuse | 168 (1.5%) | 85 (1.3%) | 172 (1.1%) | 0.02 |
Psychoses | 176 (1.6%) | 93 (1.4%) | 189 (1.3%) | 0.05 |
Depression | 294 (2.7%) | 158 (2.4%) | 380 (2.5%) | 0.49 |
Hypertension | 4746 (43.6%) | 3003 (46.0%) | 6702 (44.7%) | 0.01 |